Fentanyl citrate recalled over manufacturing violations
- Recall date
- September 23, 2025
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Park Avenue Compounding recalls Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII, 150 mL bag, Rx Only, Park Avenue Compounding, 3662…
- Recall number
- D-0178-2026
- FDA classification
- Class II
- Brand / firm
- Park Avenue Compounding
- Sold / distributed
- Distributed in Missouri
Why it was recalled
CGMP Deviations: Revised interpretation of Acceptable Quality Level (AQL) results.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Fentanyl citrate, 2 mcg / ml / Ropivacaine, 0.2% in NS 150 mL, CII, 150 mL bag, Rx Only, Park Avenue Compounding, 3662 Park Ave, Saint Louis, MO, 63110, NDC 83863-4272-1.
Get recall alerts
Free email alert whenever Park Avenue Compounding has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Park Avenue Compounding